Vivos (RDGL) Assets Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 3.90% |
| Jun 30, 2025 | 35.81% |
| Mar 31, 2025 | 36.16% |
| Dec 31, 2024 | 10.97% |
| Sep 30, 2024 | -15.24% |
| Jun 30, 2024 | -7.46% |
| Mar 31, 2024 | -18.13% |
| Dec 31, 2023 | 19.75% |
| Sep 30, 2023 | 200.20% |
| Jun 30, 2023 | 81.45% |
| Dec 31, 2022 | 241.20% |
| Sep 30, 2022 | 118.16% |
| Jun 30, 2022 | 184.17% |
| Mar 31, 2022 | 183.63% |
| Dec 31, 2021 | 362.81% |
| Sep 30, 2021 | 458.51% |
| Jun 30, 2021 | 549.18% |
| Mar 31, 2021 | 1,443.53% |
| Dec 31, 2020 | 290.89% |
| Sep 30, 2020 | 25.14% |
| Jun 30, 2020 | -7.37% |
| Dec 31, 2019 | 1.47% |
| Sep 30, 2019 | 36.62% |
| Jun 30, 2019 | -14.49% |
| Mar 31, 2019 | -43.45% |
| Dec 31, 2018 | -59.83% |
| Sep 30, 2018 | -48.00% |
| Jun 30, 2018 | -57.10% |
| Mar 31, 2018 | -79.51% |
| Dec 31, 2017 | -44.24% |
| Sep 30, 2017 | -42.39% |
| Jun 30, 2017 | 6.77% |
| Mar 31, 2017 | -56.54% |
| Dec 31, 2016 | -40.79% |
| Sep 30, 2016 | -47.09% |
| Jun 30, 2016 | -44.91% |
| Mar 31, 2016 | -25.26% |
| Dec 31, 2015 | -39.93% |
| Sep 30, 2015 | -53.30% |
| Jun 30, 2015 | -51.15% |
| Mar 31, 2015 | -56.54% |
| Dec 31, 2014 | -56.72% |
| Sep 30, 2014 | -49.77% |
| Jun 30, 2014 | -40.53% |
| Dec 31, 2013 | -57.55% |